{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:24:55Z","timestamp":1790187895759,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007217","name":"VA Health Services Research & Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jsat.2021.108353","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:34:05Z","timestamp":1614972845000},"page":"108353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study"],"prefix":"10.1016","volume":"129","author":[{"given":"Erica","family":"Morse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Timko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jsat.2021.108353_bb0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/MLR.0000000000001007","article-title":"Improving patient-centered care: How clinical staff overcome barriers to patient engagement at the VHA","volume":"56","author":"Agha","year":"2018","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0010","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.asmr.2019.10.006","article-title":"Preoperative patient education may decrease postoperative opioid use after meniscectomy","volume":"2","author":"Andelman","year":"2020","journal-title":"Arthroscopy, Sports Medicine, and Rehabilitation"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jrh.12307","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update","volume":"35","author":"Andrilla","year":"2019","journal-title":"Journal of Rural Health"},{"key":"10.1016\/j.jsat.2021.108353_bb0020","series-title":"Atlas.ti Version 8 [Computer Software]","author":"Atlas.ti Scientific Software Development GmbH","year":"2019"},{"key":"10.1016\/j.jsat.2021.108353_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.01.003","article-title":"Peer-delivered recovery support services for addictions in the United States: A systematic review","volume":"63","author":"Bassuk","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.jsat.2021.108353_bb0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108353_bb0035","first-page":"1","article-title":"Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine","author":"Brunet","year":"2020","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-020-00438-4","article-title":"Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic","volume":"17","author":"Castillo","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2021.108353_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implementation Science"},{"key":"10.1016\/j.jsat.2021.108353_bb0050","series-title":"VHA handbook 1160.1","article-title":"Uniform Mental Health Services in VA medical centers and clinics","author":"Department of Veterans Affairs","year":"2008"},{"issue":"8","key":"10.1016\/j.jsat.2021.108353_bb0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/add.14620","article-title":"Criminal justice outcomes over 5\u00a0years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder","volume":"114","author":"Evans","year":"2019","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.jsat.2021.108353_bb0060","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108353_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsat.2018.09.006","article-title":"Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science","volume":"95","author":"Finlay","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ADM.0000000000000719","article-title":"Disparities in access to medications for opioid use disorder in the Veterans Health Administration","volume":"15","author":"Finlay","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2021.108353_bb0075","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11606-020-05944-6","article-title":"Barriers to medications for opioid use disorder among veterans involved in the legal system: A qualitative study","volume":"35","author":"Finlay","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10488-015-0708-z","article-title":"Use of Veterans Health Administration mental health and substance use disorder treatment after exiting prison: The Health Care for Reentry Veterans program","volume":"44","author":"Finlay","year":"2017","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"issue":"6","key":"10.1016\/j.jsat.2021.108353_bb0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15288\/jsad.2018.79.909","article-title":"Barriers and facilitators to implementation of pharmacotherapy for opioid use disorders in VHA residential treatment programs","volume":"79","author":"Finlay","year":"2018","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","article-title":"Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","volume":"48","author":"Fox","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2021.108353_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections","volume":"50","author":"Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature","volume":"11","author":"Friedrichs","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jsat.2021.108353_bb0110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jsat.2012.10.005","article-title":"Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the United States","volume":"44","author":"Fu","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108353_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13722-019-0139-3","article-title":"Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence","volume":"14","author":"Godersky","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"3","key":"10.1016\/j.jsat.2021.108353_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108353_bb0130","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough? An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1525822X16640447","article-title":"How many interviews are enough to identify metathemes in multisited and cross-cultural research? Another perspective on Guest, Bunce, and Johnson\u2019s (2006) landmark study","volume":"29","author":"Hagaman","year":"2017","journal-title":"Field Methods"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-016-0063-8","article-title":"Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness","volume":"11","author":"Harris","year":"2016","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0155","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1097\/ADM.0000000000000682","article-title":"Low barrier tele-buprenorphine in the time of COVID-19: A case report","volume":"14","author":"Harris","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code saturation versus meaning saturation: How many interviews are enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qualitative Health Research"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0165","first-page":"118","article-title":"Health literacy in primary care practice","volume":"92","author":"Hersh","year":"2015","journal-title":"American Family Physician"},{"key":"10.1016\/j.jsat.2021.108353_bb0170","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s11606-020-05975-z","article-title":"Capsule commentary on Finlay et al., barriers to medications for opioid use disorder among veterans involved in the legal system: A qualitative study","volume":"35","author":"Howell","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2021.108353_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ajad.13055","article-title":"Mobile, community-based buprenorphine treatment for veterans experiencing homelessness with opioid use disorder: A pilot, feasibility study","volume":"29","author":"Iheanacho","year":"2020","journal-title":"American Journal of Addictions"},{"key":"10.1016\/j.jsat.2021.108353_bb0185","first-page":"1","article-title":"Patient education interventions for prescription opioids: A systematic review","author":"Kadakia","year":"2020","journal-title":"Journal of the American Pharmacists Association"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13722-019-0163-3","article-title":"Physicians\u2019 satisfaction with providing buprenorphine treatment","volume":"14","author":"Knudsen","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0195","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/08897077.2018.1439798","article-title":"Overcoming medication stigma in peer recovery: A new paradigm","volume":"39","author":"Krawczyk","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108353_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2019.06.001","article-title":"Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting","volume":"104","author":"Lam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2021.108353_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108353_bb0210","series-title":"Evidence brief: Barriers and facilitators to use of medications for opioid use disorder","author":"Mackey","year":"2019"},{"issue":"Suppl 3","key":"10.1016\/j.jsat.2021.108353_bb0215","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: A rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"Journal of General Internal Medicine."},{"key":"10.1016\/j.jsat.2021.108353_bb0220","first-page":"102841","article-title":"Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study","author":"Macmadu","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2021.108353_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108353_bb0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2019.06.014","article-title":"Provider-directed marketing may increase prescribing of medications for opioid use disorder","volume":"104","author":"Nguyen","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108353_bb0235","first-page":"108196","article-title":"Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?","author":"Nunes","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2021.108353_bb0240","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","article-title":"Barriers to use of pharmacotherapy for addiction disorders and how to overcome them","volume":"13","author":"Oliva","year":"2011","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2021.108353_bb0245","doi-asserted-by":"crossref","DOI":"10.5888\/pcd13.150567","article-title":"Tailoring care to vulnerable populations by incorporating social determinants of health: The Veterans Health Administration\u2019s \u201cHomeless Patient Aligned Care Team\u201d program","volume":"13","author":"O\u2019Toole","year":"2016","journal-title":"Preventing Chronic Disease"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0250","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/ADM.0000000000000584","article-title":"Comparing reasons for starting and stopping methadone, buprenorphine, and naltrexone treatment among a sample of white individuals with opioid use disorder","volume":"14","author":"Randall-Kosich","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2021.108353_bb0255","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/appi.ps.201400047","article-title":"Peer recovery support for individuals with substance use disorders: Assessing the evidence","volume":"65","author":"Reif","year":"2014","journal-title":"Psychiatric Services"},{"issue":"5","key":"10.1016\/j.jsat.2021.108353_bb0260","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jsat.2013.06.009","article-title":"Group management of pharmacotherapy for alcohol dependence: Feasibility and impact on adoption","volume":"45","author":"Robinson","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0265","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/add.14059","article-title":"Associations between methadone maintenance treatment and crime: A 17-year longitudinal cohort study of Canadian provincial offenders","volume":"113","author":"Russolillo","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108353_bb0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2020.01.009","article-title":"Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders","volume":"111","author":"Saunders","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/002214650704800202","article-title":"Enduring stigma: The long-term effects of incarceration on health","volume":"48","author":"Schnittker","year":"2007","journal-title":"Journal of Health and Social Behavior"},{"issue":"4","key":"10.1016\/j.jsat.2021.108353_bb0280","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MLR.0000000000001292","article-title":"Impact of transportation interventions on health care outcomes: A systematic review","volume":"58","author":"Solomon","year":"2020","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108353_bb0285","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.jsat.2021.108353_bb0290","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826084.2019.1653324","article-title":"Patient barriers and facilitators to medications for opioid use disorder in primary care","volume":"54","author":"Tofighi","year":"2019","journal-title":"Substamce Use & Misuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108353_bb0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13722-019-0166-0","article-title":"Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail","volume":"14","author":"Velasquez","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004010-200304000-00004","article-title":"Outcomes of physician job satisfaction: A narrative review, implications, and directions for future research","volume":"28","author":"Williams","year":"2003","journal-title":"Health Care Management Review"},{"issue":"3","key":"10.1016\/j.jsat.2021.108353_bb0305","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jamia\/ocv199","article-title":"Integrating patient voices into health information for self-care and patient-clinician partnerships: Veterans Affairs design recommendations for patient-generated data applications","volume":"23","author":"Woods","year":"2016","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"3","key":"10.1016\/j.jsat.2021.108353_bb0310","first-page":"348","article-title":"Risk of death for veterans on release from prison","volume":"40","author":"Wortzel","year":"2012","journal-title":"Journal of the American Academy of Psychiatry and Law"},{"issue":"2","key":"10.1016\/j.jsat.2021.108353_bb0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108353_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:12Z","timestamp":1760039652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":64,"alternative-id":["S0740547221000799"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108353","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108353"}}